Product Information
CELECOXIB 400 MG CAPSULE is a generic product labeled by Micro Labs Limited, priced at $0.2839 per EA under NDC 42571014560. Its NADAC has been published 389 times since Dec 12, 2018.
FDA first approved this application on Apr 30, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
400 mg/1
Manufacturer
Micro Labs LimitedNDC
42571014560
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
CELECOXIBApproval Type
Generic (ANDA)
FDA Application
ANDA204776FDA Approved
4/30/2018
TE Code
AB
On Market Since
6/1/2018
Pharmacological Classes
Price Statistics
The NADAC for CELECOXIB 400 MG CAPSULE has been published 389 times since Dec 12, 2018, and over the history we have for it it has declined 62.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2839 per EA |
|---|---|
| All-time high | $0.9638 (May 15, 2019) |
| All-time low | $0.2509 (Dec 17, 2025) |
| 52-week high | $0.3409 |
| 52-week low | $0.2509 |
| Median price | $0.4497 |
| Average price | $0.5400 |
| Largest weekly change | +54.7% (Jun 22, 2022) |
| Weeks tracked | 389 |
| Tracking since | Dec 12, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
-16.7%
1Y
-13.1%
3Y
-10.6%
5Y
-63.0%
All
-62.5%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 22% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Micro Labs Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Celecoxib market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CELECOXIB 400 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CELECOXIB 400 MG CAPSULE, manufactured by Micro Labs Limited, is $0.2839 per EA (NDC 42571014560), effective May 20, 2026.
How has the price of CELECOXIB 400 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CELECOXIB 400 MG CAPSULE has declined 62.5%. It has been tracked across 389 weekly CMS publications since Dec 12, 2018.
What are the highest and lowest recorded NADAC prices for CELECOXIB 400 MG CAPSULE?
Since Dec 12, 2018, the NADAC for CELECOXIB 400 MG CAPSULE has ranged from a low of $0.2509 (Dec 17, 2025) to a high of $0.9638 (May 15, 2019), with a median of $0.4497 per EA.
Are there cheaper alternatives to CELECOXIB 400 MG CAPSULE?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CELECOXIB 400 MG CAPSULE, is $0.2228 per EA — about 22% below CELECOXIB 400 MG CAPSULE.
Who manufactures CELECOXIB 400 MG CAPSULE?
CELECOXIB 400 MG CAPSULE (NDC 42571014560) is labeled by Micro Labs Limited, and CMS classifies it as a generic product.